Secondary analysis of BARI 2D (2,277 with type 2 diabetes and coronary disease): suPAR did not fall with diabetes or revascularisation strategies while hs-CRP did, and predicted death, MI or stroke (adjusted HR 1.40 per SD) independent of hs-CRP.
Secondary analysisn = 2,277
Ismail et al. suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D